BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/14/2022 7:20:14 AM | Browse: 485 | Download: 1307
 |
Received |
|
2022-10-11 02:15 |
|
Peer-Review Started |
|
2022-10-11 02:17 |
|
First Decision by Editorial Office Director |
|
2022-11-02 03:15 |
|
Return for Revision |
|
2022-11-02 03:15 |
|
Revised |
|
2022-11-10 02:22 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-11-24 03:06 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-11-24 06:45 |
|
Articles in Press |
|
2022-11-24 06:45 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-11-30 15:55 |
|
Publish the Manuscript Online |
|
2022-12-14 07:20 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Urology & Nephrology |
| Manuscript Type |
Case Report |
| Article Title |
Response to roxadustat in a patient undergoing long-term dialysis and allergic to erythropoiesis-stimulating agents: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Cai Xu, Deng-Gui Luo, Zhe-Yan Liu, Dong Yang, Dan-Dan Wang, Yuan-Zhao Xu, Jun Yang, Bo Fu and Ai-Rong Qi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ai-Rong Qi, PhD, Chief Physician, Department of Nephrology, The Fourth Affiliated Hospital of Guangzhou University of Chinese Medicine, No. 1 Fuhua Road, Futian District, Shenzhen, Shenzhen 518000, Guangdong Province, China. 81863418@163.com |
| Key Words |
Chronic kidney disease; Hemodialysis; Anemia; Roxadustat; Erythropoiesis- stimulating agents; Allergic shock; Case report |
| Core Tip |
Anemia of dialysis-dependent chronic kidney disease is commonly treated with erythropoiesis-stimulating agents (ESAs), along with iron supplementation; however, in some cases, patients cannot be administered erythropoiesis-stimulating agents. Roxadustat is a newly developed drug for renal anemia treatment. It is an oral hypoxia-inducible factor-prolyl hydroxylase inhibitor (HIF-PHI) that stimulates erythropoiesis and regulates iron metabolism. In this study, we presented a case in which Roxadustat was administered for the treatment of a patient allergic to ESAs. This was the first case where roxadustat was administered to improve anemia in a patient allergic to ESAs and on maintenance hemodialysis. |
| Publish Date |
2022-12-14 07:20 |
| Citation |
Xu C, Luo DG, Liu ZY, Yang D, Wang DD, Xu YZ, Yang J, Fu B, Qi AR. Response to roxadustat in a patient undergoing long-term dialysis and allergic to erythropoiesis-stimulating agents: A case report. World J Clin Cases 2022; 10(35): 13122-13128 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i35/13122.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i35.13122 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
